Vycor Medical (VYCO) Research & Development (2010 - 2025)
Vycor Medical (VYCO) reported Research & Development of $4201.0 for Q2 2025, up 85.64% year-over-year from $2263.0 in Q2 2024, and down 27.09% on a QoQ basis from $5762.0 in Q1 2025.
Vycor Medical (VYCO) has 11 years of Research & Development data on file, last reported at $4201.0 in Q2 2025.
- Quarterly Research & Development rose 85.64% year-over-year to $4201.0 in Q2 2025, while the trailing twelve-month figure through Dec 2025 was $9963.0 (down 43.31% YoY) and the FY2025 annual result came in at $9963.0, down 34.99% from the prior year.
- Research & Development fell to $4201.0 in Q2 2025 per VYCO's latest filing, from $5762.0 in the prior quarter.
- Across five years, Research & Development topped out at $7550.0 in Q2 2023 and bottomed at $1825.0 in Q3 2021.
- The 4-year median for Research & Development is $5508.0 (2023), against an average of $4846.5.
- Peak annual rise in Research & Development reached 194.98% in 2024, while the deepest fall reached 70.03% in 2024.
- Tracing VYCO's Research & Development over 4 years: stood at $6705.0 in 2021, then tumbled by 66.44% to $2250.0 in 2023, then jumped by 194.98% to $6637.0 in 2024, then plunged by 36.7% to $4201.0 in 2025.
- Per Business Quant, the three latest VYCO Research & Development figures stand at $4201.0 (Q2 2025), $5762.0 (Q1 2025), and $6637.0 (Q4 2024).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | R&D (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn | 767.00 Mn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn | 413.00 Mn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn | 722.00 Mn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn | 516.00 Mn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn | 263.30 Mn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | -461.27 Mn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn | 145.30 Mn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn | 345.00 Mn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn | 28.80 Mn |
| 10 | Vycor Medical | - | - | 375,153.00 | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2025 | 4,201.00 |
| Mar 31, 2025 | 5,762.00 |
| Dec 31, 2024 | 6,637.00 |
| Sep 30, 2024 | 6,425.00 |
| Jun 30, 2024 | 2,263.00 |
| Dec 31, 2023 | 2,250.00 |
| Sep 30, 2023 | 7,250.00 |
| Jun 30, 2023 | 7,550.00 |
| Mar 31, 2023 | 5,508.00 |
| Dec 31, 2021 | 6,705.00 |
| Sep 30, 2021 | 1,825.00 |
| Jun 30, 2021 | 3,929.00 |
| Mar 31, 2021 | 2,700.00 |
| Dec 31, 2016 | 586.00 |
| Sep 30, 2016 | 4,153.00 |
| Dec 31, 2015 | 3,268.00 |
| Sep 30, 2015 | 29,346.00 |
| Jun 30, 2015 | 15,672.00 |
| Mar 31, 2015 | 23,226.00 |
| Sep 30, 2014 | 6,933.00 |
| Jun 30, 2014 | 37,395.00 |
| Mar 31, 2014 | 15,356.00 |
| Dec 31, 2013 | 816.00 |
| Jun 30, 2013 | 21,285.00 |
| Mar 31, 2013 | 31,350.00 |
| Dec 31, 2012 | 21,845.00 |
| Sep 30, 2012 | 33,650.00 |
| Jun 30, 2012 | 45,860.00 |
| Mar 31, 2012 | 24,687.00 |
| Dec 31, 2011 | 20,705.00 |
| Sep 30, 2011 | 33,624.00 |
| Jun 30, 2011 | 37,484.00 |
| Mar 31, 2011 | 23,852.00 |
| Dec 31, 2010 | 5,551.00 |
| Sep 30, 2010 | 4,009.00 |
| Jun 30, 2010 | 762.00 |